There has been reported that the expression of NHE-1 was enhanced in cardiomyocytes exposed to high glucose and cariporide, a NHE inhibitor, could ameliorate the high glucose-induced myocardial hypertrophy (Chen et al., 2007). Here, SLC9A1 is linked to cardiac hypertrophy.